AEMD Aethlon Medical, Inc. - Common Stock
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 13, 2026
$6.45
· of 52w range
· above low
· to high
$1.4152w low
$40.5052w high
Market Cap (MRQ)
$3M
P/E
-0.1
EPS
$-10.61
Revenue
$0
your badges
52W Range
$1–$40
Analyst Rating
HOLD
Price Target
$13
P/E
-0.1
ROE
-134.5%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
AEMD Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$6.45
Market Cap (MRQ)
$3M
P/E
-0.1
EPS
$-10.61
Revenue
$0
ROE
-134.5%
52W Range
$1–$41
AEMD Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Aug. 4, 2026 | 1-for-5 | Reverse |
| Oct. 20, 2025 | 1-for-10 | Reverse |
| June 9, 2025 | 1-for-8 | Reverse |
| Oct. 5, 2023 | 1-for-10 | Reverse |
| Oct. 15, 2019 | 1-for-15 | Reverse |
| April 14, 2015 | 1-for-50 | Reverse |
About Aethlon Medical, Inc. - Common Stock Company overview from Wikipedia
sectorHealth Care
industryHealth Care
employees9
countryUS
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$02021-03-31 → 2024-03-31
EPS$-10.612022-03-31 → 2026-03-31
Free Cash Flow$-7M2021-03-31 → 2026-03-31
Net margin·2021-03-31 → 2023-03-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | AEMD | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -0.15Y avg ≈-340.8 | ≈-340.8 | · | · | |
| P/S | 118.45Y avg ≈19244.7 | ≈19244.7 | 3.7 | Fair value | |
| P/B (MRQ) | 0.65Y avg ≈381.8 | ≈381.8 | 2.7 | Undervalued | |
| Price / FCF | -0.35Y avg ≈-599.7 | ≈-599.7 | · | · | |
| Price / Cash Flow | -0.35Y avg ≈-629.3 | ≈-629.3 | · | · | |
| Price / Tangible Book | 0.45Y avg ≈319.5 | ≈319.5 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | AEMD | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -104.5%5Y avg ≈-96.8% | ≈-96.8% | -59.4% | Weak | |
| ROE | -134.5%5Y avg ≈-142.6% | ≈-142.6% | -134.5% | In line | |
| ROIC | -149.3% | · | -176.5% | In line |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | AEMD | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 5.45Y avg ≈6.7 | ≈6.7 | 1.8 | Strong liquidity | |
| Quick Ratio | 3.55Y avg ≈6.4 | ≈6.4 | 1.2 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | AEMD | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue / Employee | ≈$0.00 | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-206.7%
Next Report
Nov 10, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| March 31, 2027 | Aug 13, 2026 | $-4.02 | $-0.80 | -402.1% |
| June 30, 2026 | Aug 13, 2026 | $-4.02 | $-0.80 | -402.1% |
| March 31, 2026 | $-1.49 | $-2.06 | 27.3% | |
| Dec. 31, 2025 | $-2.45 | $-2.47 | 0.75% | |
| Sept. 30, 2025 | $-3.74 | $-3.74 | -0.09% | |
| June 30, 2025 | $-8.50 | $-8.77 | 3.1% | |
| March 31, 2025 | $-79.70 | $-10.30 | -673.6% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $574.2K | $294.2K | $659.1K | $650.2K | $229.6K | $149.6K | $392.1K | $886.6K | $762.4K | |
| R&D Expense | $2M | $2M | $3M | $3M | $2M | $2M | $927.0K | $896.0K | $586.0K | $673.0K | $782.0K | $1M | |
| SG&A Expense | $3M | $3M | $4M | $4M | $3M | $2M | $2M | $953.5K | $792.6K | $849.5K | $929.0K | $907.1K | |
| Operating Expenses | $7M | $9M | $13M | $12M | $11M | $9M | $7M | $6M | $5M | $6M | $5M | $5M | |
| Operating Income | $-7M | $-9M | $-13M | $-12M | $-10M | $-8M | $-6M | $-6M | $-5M | $-6M | $-4M | $-4M | |
| Interest Expense | · | $10.1K | · | · | · | · | · | · | · | · | $125.6K | $298.0K | |
| Interest Income | $156.5K | $298.1K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $142.2K | $-4M | · | · | · | $-1.6K | $-450.1K | $-220.5K | · | · | · | · | |
| Pretax Income | $-7M | $-13M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-7M | $-13M | $-12M | $-12M | $-10M | $-8M | $-6M | $-6M | $-6M | $-7M | $-5M | $-7M | |
| EPS (Basic) | $-10.61 | $-85.77 | $-38.87 | $-5.86 | $-0.71 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-10.61 | $-85.77 | $-38.87 | $-5.86 | $-0.71 | · | · | · | · | · | · | · | |
| Shares (Basic) | 673,945 | 156,085 | 314,097 | 2,053,744 | 14,756,967 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 673,945 | 156,085 | 314,097 | 2,053,744 | 14,756,967 | · | · | · | · | · | · | · | |
| EBITDA | $-7M | $-9M | · | $-12M | $-10M | $-8M | $-6M | $-6M | $-5M | $-6M | $-4M | $-4M |
Balance Sheet
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $6M | $5M | $15M | $17M | $10M | $10M | $4M | $7M | $2M | $2M | $855.6K | |
| Receivables | · | · | · | $0 | $128.0K | $149.1K | $206.7K | $0 | $74.8K | $0 | $199.5K | $193.3K | |
| Prepaid Expense | $332.1K | $448.5K | $506.0K | $557.6K | $956.6K | $341.1K | $229.6K | $210.0K | $181.4K | $37.6K | $53.3K | $73.1K | |
| Current Assets | $6M | $6M | $6M | $15M | $18M | $10M | $10M | $4M | $7M | $2M | $2M | $1M | |
| PP&E (Net) | $356.8K | $676.2K | $1M | $1M | $441.2K | $161.0K | $140.5K | $6.0K | $27.6K | $29.2K | $36.0K | $56.1K | |
| PP&E (Gross) | $2M | $2M | $2M | $990.0K | $813.4K | $585.9K | $526.0K | $374.4K | $376.9K | $352.1K | $394.4K | $385.1K | |
| Accum. Depreciation | $1M | $978.9K | $990.5K | $734.2K | $493.9K | $424.9K | $385.5K | $368.3K | $349.4K | $322.9K | $358.4K | $329.0K | |
| Intangibles | $0 | $550 | $1.1K | $1.6K | $2.2K | $57.0K | $57.5K | $66.7K | $75.8K | $85.0K | $94.2K | $103.3K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | $22.4K | $16.8K | |
| Total Assets | $6M | $7M | $8M | $18M | $19M | $11M | $10M | $4M | $7M | $2M | $3M | $1M | |
| Accounts Payable | $384.6K | $534.5K | $777.9K | $432.9K | $500.0K | $337.7K | $285.0K | $131.9K | $124.5K | $484.4K | $244.8K | $342.1K | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Current Liabilities | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $478.0K | $611.8K | $526.6K | $574.0K | |
| Capital Leases | $0 | $336.7K | $649.8K | $939.6K | $602.5K | $0 | $42.5K | $0 | · | · | · | · | |
| Total Liabilities | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | $1M | $1M | $729.2K | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Common Stock | $314 | $259 | $329 | $2.3K | $15.4K | $12.2K | $9.4K | $1.3K | $17.7K | $8.8K | $7.6K | $6.7K | |
| Paid-in Capital | $180M | $173M | $160M | $157M | $147M | $129M | $121M | $108M | $106M | $94M | $88M | $82M | |
| Retained Earnings | $-175M | $-168M | $-155M | $-142M | $-130M | $-120M | $-112M | $-106M | $-99M | $-94M | $-87M | $-82M | |
| AOCI | $-32.7K | $-17.1K | $-6.9K | $-6.1K | $0 | · | · | · | · | · | · | · | |
| Stockholders' Equity | $5M | $5M | $6M | $15M | $17M | $9M | $9M | $2M | $6M | $676.4K | $2M | $615.5K | |
| Liabilities + Equity | $6M | $7M | $8M | $18M | $19M | $11M | $10M | $4M | $7M | $2M | $3M | $1M | |
| Shares Outstanding | 314,100 | 201,074 | 328,728 | 2,299,259 | 15,419,163 | 15,419,163 | 9,366,873 | 1,266,979 | 17,739,511 | 8,797,086 | 7,622,393 | 6,657,046 |
Cash Flow
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $323.7K | $339.6K | $359.1K | $240.9K | $123.7K | $39.9K | $26.4K | $30.7K | $35.7K | $32.4K | $38.5K | $37.4K | |
| Stock-based Comp | $278.5K | $415.2K | $1M | $1M | $750.6K | $779.4K | $844.0K | $1M | $1M | $2M | $202.8K | $416.5K | |
| Amort. of Intangibles | $550 | $550 | $550 | $550 | $54.8K | $550 | $9.2K | $9.2K | $9.2K | $9.2K | $9.0K | $9.0K | |
| Other Non-cash | $-449.1K | $5M | · | $231.9K | $-225.4K | $302.4K | $306.0K | $551.6K | $472.5K | $2M | $301.7K | $1M | |
| Operating Cash Flow | $-7M | $-8M | $-10M | $-11M | $-10M | $-7M | $-5M | $-4M | $-4M | $-4M | $-4M | $-5M | |
| CapEx | $3.7K | $0 | $250.9K | $943.1K | $349.2K | $59.9K | $151.7K | $0 | $24.8K | $16.4K | $9.3K | $0 | |
| Investing Cash Flow | $-3.7K | $0 | $-250.9K | $-943.1K | $-349.2K | $-59.9K | $-151.7K | $0 | $-24.8K | $-16.4K | $-9.3K | $0 | |
| Stock Issued | $7M | $5M | $1M | $9M | · | · | · | · | · | · | $6M | $5M | |
| Net Stock Activity | $7M | $4M | · | · | · | · | · | · | · | · | $6M | $5M | |
| Financing Cash Flow | $7M | $8M | $1M | $9M | $17M | $7M | $11M | $1M | $9M | $3M | $6M | $5M | |
| Net Change in Cash | $-473.7K | $69.6K | $-9M | $-3M | $7M | · | · | · | · | · | · | · | |
| Free Cash Flow | $-7M | $-8M | · | $-11M | $-10M | $-7M | $-5M | $-4M | $-4M | $-4M | $-4M | $-5M |
Profitability
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -2072.1% | -3542.5% | -1197.1% | -912.0% | -2612.5% | -3228.8% | -1555.4% | -494.6% | -523.7% | |
| Net Margin | · | · | · | -2094.9% | -3540.9% | -1196.6% | -980.3% | -2697.8% | -3795.9% | -1855.8% | -549.6% | -891.5% | |
| EBITDA Margin | · | · | · | -2030.1% | -3500.5% | -1191.0% | -908.0% | -2599.2% | -3205.0% | -1547.2% | -490.2% | -518.8% | |
| ROA | -104.5% | -171.6% | · | -65.1% | -46.0% | -67.6% | -84.6% | -136.5% | -86.7% | -578.4% | -158.5% | -299.6% | |
| ROE | -134.5% | -283.1% | · | -74.4% | -78.4% | -83.7% | -107.7% | -144.8% | -166.8% | -652.8% | -449.4% | 94.8% | |
| ROIC | -149.3% | · | · | · | · | · | · | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 3.1 | · | 10.0 | 10.0 | 7.5 | 9.4 | 2.2 | 15.1 | 2.6 | 4.6 | 2.1 | |
| Quick Ratio | 3.5 | 2.9 | · | 9.7 | 9.4 | 7.3 | 9.2 | 2.1 | 14.7 | 2.5 | 4.4 | 1.8 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | |
| Interest Coverage | · | -924.1 | · | · | · | · | · | · | · | · | · | -11.4 |
Efficiency
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.3 | 0.3 | 0.3 | |
| Receivables Turnover | · | · | · | 9.0 | 2.1 | 3.7 | 6.3 | 6.1 | 4.0 | 3.9 | 4.5 | 5.3 |
Per Share
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.11 | $2.55 | · | $0.66 | $1.11 | $0.78 | $1.00 | $0.13 | $0.35 | $0.08 | $0.20 | $0.09 | |
| Revenue / Share | · | · | · | $0.03 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-10.38 | $-4.90 | · | $-0.51 | · | · | · | · | · | · | · | · | |
| Cash / Share | $3.20 | $2.74 | · | $0.63 | $1.11 | $0.81 | $1.03 | $0.20 | $0.39 | $0.18 | $0.28 | $0.13 | |
| EPS (TTM) | $-10.61 | $-8.58 | $-38.87 | $-5.86 | $-0.71 | · | · | · | · | · | · | · |
Growth Rates
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | 95.2% | -55.4% | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $17.1K | $17.1K | $0 | $574.2K | $294.2K | $659.1K | $650.2K | $229.6K | $149.6K | $392.1K | $886.6K | $762.4K | |
| Net Income TTM | $-7M | $-13M | $-12M | $-12M | $-10M | $-8M | $-6M | $-6M | $-6M | $-7M | $-5M | $-7M | |
| Market Cap | $3M | $58M | · | $6.99B | $18.01B | $19.73B | $11.39B | $216.65B | $253.32B | $345.20B | $490.27B | $918.67B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $918.67B | |
| P/E | -0.2 | -3.4 | -3.5 | -51.9 | -1645.1 | · | · | · | · | · | · | · | |
| P/S | 200.9 | 3383.1 | · | 12172.0 | 61222.7 | 29938.5 | 17518.8 | 943488.2 | 1693034.0 | 880442.3 | 552997.7 | 1204947.4 | |
| P/B | 0.7 | 11.3 | · | 464.0 | 1051.2 | 2092.4 | 1210.5 | 89335.6 | 41297.5 | 510361.3 | 315750.6 | 1492684.0 | |
| P / Tangible Book | 0.7 | 11.3 | 61.3 | 464.0 | 1060.1 | 2105.1 | · | · | · | · | · | · | |
| P / Cash Flow | -0.5 | -7.6 | · | -665.4 | -1843.9 | -2916.9 | -2191.5 | -50460.4 | -64776.5 | -98461.9 | -113245.0 | -181936.4 | |
| P / FCF | -0.5 | -7.6 | · | -610.5 | -1780.2 | -2891.3 | -2129.4 | -50460.4 | -64367.9 | -98002.6 | -113002.1 | -181936.4 | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | -232251.6 | |
| EV / FCF | · | · | · | · | · | · | · | · | · | · | · | -181936.3 | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 1204946.2 | |
| Earnings Yield | -484.5% | -29.8% | -28.9% | -1.9% | -0.06% | · | · | · | · | · | · | · |
Income Statement
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | $574.2K | $0 | $0 | |
| R&D Expense | $549.0K | $560.5K | $532.8K | $294.3K | $524.0K | $1M | $240.2K | $261.5K | $414.7K | $619.2K | $593.4K | $628.4K | $678.9K | $476.0K | $558.2K | $852.5K | |
| SG&A Expense | $662.5K | $698.0K | $741.6K | $521.4K | $735.4K | $716.4K | $816.4K | $958.4K | $752.0K | $764.9K | $979.2K | $850.8K | $1M | $829.1K | $1M | $2M | |
| Operating Expenses | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $4M | $3M | $3M | $3M | $3M | $4M | |
| Operating Income | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-2M | $-4M | $-3M | $-3M | $-2M | $-3M | $-4M | |
| Other Non-op | · | · | · | · | $-5.9K | · | · | · | $0 | · | · | · | · | · | · | · | |
| Net Income | $-2M | $-2M | $-2M | $-1M | $-2M | $-6M | $-2M | $-3M | $-3M | $-2M | $-3M | $-3M | $-3M | $-2M | $-3M | $-4M | |
| EPS (Basic) | $-4.02 | $-3.57 | $-2.45 | $-3.74 | $-42.42 | $-56.85 | $-10.05 | $-16.11 | $-2.76 | $-34.93 | $-1.37 | $-1.22 | $-1.35 | $-2.59 | $-1.24 | $-1.84 | |
| EPS (Diluted) | $-4.02 | $-3.57 | $-2.45 | $-3.74 | $-42.42 | $-56.85 | $-10.05 | $-16.11 | $-2.76 | $-34.93 | $-1.37 | $-1.22 | $-1.35 | $-2.59 | $-1.24 | $-1.84 | |
| Shares (Basic) | 384,705 | · | 823,126 | 397,513 | 41,529 | · | 174,529 | 174,220 | 932,248 | · | 2,516,511 | 2,483,649 | 2,431,476 | · | 2,294,649 | 2,074,500 | |
| Shares (Diluted) | 384,705 | · | 823,126 | 397,513 | 41,529 | · | 174,529 | 174,220 | 932,248 | · | 2,516,511 | 2,483,649 | 2,431,476 | · | 2,294,649 | 2,074,500 | |
| EBITDA | $-2M | · | $-2M | $-2M | $-2M | · | $-2M | $-3M | $-3M | · | $-4M | $-3M | $-3M | · | $-3M | $-4M |
Balance Sheet
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $5M | $7M | $6M | $4M | $6M | $5M | $7M | $9M | $5M | $8M | $10M | $13M | $15M | $17M | $20M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $114.8K | |
| Prepaid Expense | $283.1K | $332.1K | $185.1K | $182.1K | $276.6K | $448.5K | $88.3K | $279.0K | $478.1K | $506.0K | $277.3K | $311.4K | $410.2K | $557.6K | $672.8K | $784.6K | |
| Current Assets | $6M | $6M | $7M | $6M | $4M | $6M | $5M | $7M | $10M | $6M | $8M | $10M | $13M | $15M | $18M | $21M | |
| PP&E (Net) | $293.1K | $356.8K | $434.2K | $514.0K | $593.7K | $676.2K | $762.1K | $843.6K | $929.3K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $990.0K | · | · | |
| Accum. Depreciation | · | $1M | · | · | · | $978.9K | · | · | · | $990.5K | · | · | · | $734.2K | · | · | |
| Intangibles | · | $0 | $138 | $275 | $413 | $550 | $688 | $825 | $963 | $1.1K | $1.2K | $1.4K | $1.5K | $1.6K | $1.8K | $1.9K | |
| Total Assets | $6M | $6M | $8M | $7M | $5M | $7M | $7M | $9M | $11M | $8M | $10M | $13M | $16M | $18M | $21M | $23M | |
| Accounts Payable | $411.4K | $384.6K | $469.5K | $570.8K | $571.5K | $534.5K | $610.9K | $922.9K | $1M | $777.9K | $693.2K | $684.9K | $844.5K | $432.9K | $226.8K | $361.0K | |
| Current Liabilities | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Capital Leases | · | $0 | $86.9K | $172.1K | $255.1K | $336.7K | $417.5K | $496.8K | $573.9K | $649.8K | $724.8K | $798.5K | $869.9K | $939.6K | $1M | $1M | |
| Total Liabilities | · | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $3M | |
| Common Stock | $477 | $1.6K | $973 | $761 | $2.6K | $259 | $14.0K | $14.0K | $13.9K | $329 | $2.6K | $2.5K | $24.8K | $2.3K | $23.0K | $22.9K | |
| Paid-in Capital | $182M | $180M | $180M | $177M | $173M | $173M | $166M | $166M | $166M | $160M | $160M | $159M | $159M | $157M | $157M | $157M | |
| Retained Earnings | $-177M | $-175M | $-173M | $-171M | $-170M | $-168M | $-162M | $-160M | $-157M | $-155M | $-152M | $-149M | $-146M | $-142M | $-140M | $-137M | |
| AOCI | $-38.9K | $-32.7K | $-29.8K | $-26.4K | $-22.4K | $-17.1K | $-17.0K | $-4.0K | $-7.8K | $-6.9K | $-1.6K | $-9.6K | $-7.1K | $-6.1K | · | · | |
| Stockholders' Equity | $5M | $5M | $7M | $6M | $3M | $5M | $4M | $6M | $9M | $6M | $8M | $10M | $13M | $15M | $17M | $20M | |
| Liabilities + Equity | $6M | $6M | $8M | $7M | $5M | $7M | $7M | $9M | $11M | $8M | $10M | $13M | $16M | $18M | $21M | $23M | |
| Shares Outstanding | 477,402 | 1,570,449 | 973,213 | 761,318 | 2,598,711 | 201,074 | 13,986,669 | 13,961,998 | 13,937,327 | 328,728 | 2,596,538 | 2,492,908 | 24,835,321 | 2,299,259 | 22,969,349 | 22,946,232 |
Cash Flow
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $72.9K | $79.5K | $81.6K | $79.9K | $82.6K | $83.9K | $83.8K | $85.8K | $86.1K | $85.8K | $91.5K | $91.4K | $90.3K | $79.5K | $78.1K | $52.6K | |
| Stock-based Comp | $50.0K | $61.2K | $72.4K | $72.4K | $72.4K | $72.4K | $90.0K | $113.5K | $139.3K | $139.1K | $573.0K | $257.2K | $250.1K | $260.3K | $262.6K | $313.5K | |
| Other Non-cash | $-471.5K | · | · | · | $-108.2K | · | · | · | $598.5K | · | · | · | $459.4K | · | · | · | |
| Operating Cash Flow | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-3M | $-2M | $-3M | $-2M | $-3M | |
| CapEx | $9.2K | $2.1K | · | · | $0 | $-2.2K | $2.2K | $0 | $0 | $4.9K | $8.8K | $6.8K | $230.4K | $11.3K | $151.5K | $739.2K | |
| Investing Cash Flow | $-9.2K | $-2.1K | · | · | $0 | $2.2K | $-2.2K | $0 | $0 | $-4.9K | $-8.8K | $-6.8K | $-230.4K | $-11.3K | $-151.5K | $-739.2K | |
| Stock Issued | $2M | $-848.5K | $4M | $4M | $0 | $-680.5K | $0 | $0 | $4M | $49.8K | $186.5K | $0 | $1M | $0 | $0 | $8M | |
| Net Stock Activity | $2M | · | · | · | $0 | · | · | · | $4M | · | · | · | $1M | · | · | · | |
| Financing Cash Flow | $2M | $-196.5K | $3M | $4M | $-5.4K | $2M | $-7.1K | $-3.8K | $5M | $42.6K | $177.1K | $-9.8K | $1M | $-2.6K | $-1.9K | $8M | |
| Net Change in Cash | $-92.7K | $-2M | $1M | $2M | $-2M | $686.2K | $-2M | $-2M | $4M | $-3M | $-2M | $-3M | $-2M | $-3M | $-2M | $5M | |
| Free Cash Flow | $-2M | · | · | · | · | · | · | · | $-2M | · | · | · | $-3M | · | · | · |
Profitability
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -5047.0% | · | -4700.4% | -6642.4% | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -4947.0% | · | -4600.4% | -6542.4% | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -4814.1% | · | -4700.4% | -6642.4% | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -26.8% | · | -27.7% | -18.4% | -21.1% | · | -20.7% | -25.9% | -18.9% | · | -22.2% | -16.9% | -19.9% | · | -13.4% | · | |
| ROE | -35.9% | · | -36.5% | -25.3% | -29.0% | · | -29.4% | -34.4% | -23.6% | · | -27.9% | -20.1% | -23.3% | · | -15.0% | · |
Liquidity & Solvency
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.4 | · | 5.7 | 4.5 | 2.5 | · | 2.8 | 3.1 | 4.5 | · | 3.9 | 6.1 | 7.3 | · | 7.5 | 9.8 | |
| Quick Ratio | 4.8 | · | 5.5 | 4.2 | 2.3 | · | 2.7 | 2.9 | 4.3 | · | 3.8 | 5.9 | 7.1 | · | 7.2 | 9.4 |
Efficiency
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 |
Per Share
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $10.89 | · | $6.90 | $7.55 | $1.32 | · | $0.31 | $0.43 | $0.63 | · | $2.93 | $4.14 | $0.53 | · | $0.75 | $0.87 | |
| Revenue / Share | $0.08 | · | $0.05 | $0.06 | · | · | · | · | · | · | · | · | · | · | $0.00 | $0.00 | |
| Cash Flow / Share | $-4.93 | · | · | · | $-0.83 | · | · | · | $-0.23 | · | · | · | $-0.10 | · | · | · | |
| Cash / Share | $10.33 | · | $7.15 | $7.69 | $1.45 | · | $0.34 | $0.49 | $0.65 | · | $3.07 | $4.08 | $0.52 | · | $0.76 | $0.85 | |
| EPS (TTM) | $-13.78 | · | $-105.46 | $-113.06 | $-125.43 | · | $-63.85 | $-55.17 | $-40.28 | · | $-6.53 | $-6.40 | $-7.02 | · | $-3.53 | $-2.45 |
Valuation (TTM)
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $574.2K | · | $574.2K | $574.2K | $574.2K | · | $574.2K | $574.2K | $574.2K | · | $574.2K | $574.2K | $574.2K | · | $13.1K | $30.2K | |
| Net Income TTM | $-7M | · | $-12M | $-11M | $-13M | · | $-10M | $-11M | $-11M | · | $-12M | $-12M | $-12M | · | $-13M | $-13M | |
| Market Cap | $391.5K | · | $3M | $6M | $31M | · | $962M | $525M | $557M | · | $455M | $459M | $7.15B | · | $5.15B | $10.65B | |
| P/E | -0.3 | · | -0.1 | -0.3 | -0.5 | · | -5.4 | -3.4 | -5.0 | · | -134.2 | -143.8 | -205.1 | · | -317.3 | -946.9 | |
| P/S | 3.4 | · | 23.5 | 49.7 | 271.5 | · | 8378.7 | 4571.0 | 4854.1 | · | 3961.0 | 3993.9 | 62278.1 | · | 1961396.1 | 1760832.8 | |
| P/B | 0.1 | · | 0.4 | 1.0 | 9.1 | · | 222.0 | 87.2 | 64.0 | · | 59.8 | 44.5 | 545.6 | · | 297.8 | 535.9 | |
| P / Tangible Book | 0.1 | · | 0.4 | 1.0 | 9.1 | · | 222.1 | 87.2 | 64.0 | · | 59.8 | 44.5 | 545.7 | · | 297.8 | 535.9 | |
| P / Cash Flow | -0.2 | · | · | · | -18.2 | · | · | · | -319.0 | · | · | · | -2881.3 | · | · | · | |
| Earnings Yield | -336.1% | · | -761.4% | -301.5% | -209.1% | · | -18.6% | -29.3% | -20.1% | · | -0.75% | -0.70% | -0.49% | · | -0.32% | -0.11% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Revenue | · | · | $0 | $574.2K | $294.2K |
| Operating Margin % | · | · | · | -2072.1% | -3542.5% |
| Net Income | $-7M | $-13M | $-12M | $-12M | $-10M |
| Diluted EPS | $-10.61 | $-85.77 | $-38.87 | $-5.86 | $-0.71 |
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Current Ratio | 3.8 | 3.1 | · | 10.0 | 10.0 |
| Quick Ratio | 3.5 | 2.9 | · | 9.7 | 9.4 |
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-7M | $-8M | · | $-11M | $-10M |
Institutional owners (13F) 17 filers · $136K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
17
Value held
$136K
New positions
7
Exited positions
2
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 7 (+1 vs prior Q) | 2 (0 vs prior Q) | 4 (+4 vs prior Q) | 1 (+1 vs prior Q) | +195K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | $35,387 | 42,977 | 25.99% | Shares |
| JANE STREET GROUP, LLC | $32,014 | 38,880 | 23.51% | Shares |
| Shay Capital LLC | $25,585 | 31,072 | 18.79% | Shares |
| Ikarian Capital, LLC | $11,827 | 14,364 | 8.69% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $8,389 | 10,189 | 6.16% | Shares |
| Scientech Research LLC | $8,278 | 10,054 | 6.08% | Shares |
| UBS Group AG | $7,305 | 8,876 | 5.37% | Shares |
| Tower Research Capital LLC (TRC) | $5,213 | 6,331 | 3.83% | Shares |
| MORGAN STANLEY | $2,035 | 2,472 | 1.49% | Shares |
| HRT FINANCIAL LP | $59 | 72,743 | 0.04% | Shares |
| Virtu Financial LLC | $23 | 27,815 | 0.02% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $15 | 17 | 0.01% | Shares |
| GROUP ONE TRADING LLC | $12 | 14 | 0.01% | Shares |
| BlackRock, Inc. | $8 | 10 | 0.01% | Shares |
| WELLS FARGO & COMPANY/MN | $2 | 3 | 0.00% | Shares |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $2 | 2 | 0.00% | Shares |
| DANSKE BANK A/S | $1 | 1 | 0.00% | Shares |
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Ellen R. Weiner Family Revocable Trust | Feb. 18, 2015 | · | Initial filing | · | SEC |
| Undisclosed reporting person | Dec. 16, 2005 | · | Initial filing | · | SEC |
| Undisclosed reporting person | Dec. 16, 2005 | · | Initial filing | · | SEC |
| Undisclosed reporting person | Nov. 23, 2005 | · | Initial filing | Passive investment | SEC |
| Undisclosed reporting person | Nov. 23, 2005 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 17 insiders · 9 officers · 12 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Charles J Fisher JR | Chief Executive Officer | Feb. 10, 2022 A | 19,569 | 0 | 0 | $0 |
| Timothy C Rodell JR | Chief Executive Officer | April 3, 2020 A | · | 0 | 0 | $0 |
| James A Joyce | Chairman, CEO, Secretary | Oct. 31, 2018 C | 212,370 | 0 | 0 | $0 |
| James B Frakes | CFO & Sr. VP ? Finance | Feb. 10, 2022 A | 2,483 | 0 | 0 | $0 |
| Rodney S Kenley | President | Oct. 31, 2018 C | 20,358 | 0 | 0 | $0 |
| Lee D Arnold | Chief Scientific Officer | Feb. 1, 2023 A | · | 0 | 0 | $0 |
| Steven P Larosa | Chief Medical Officer | Feb. 10, 2022 A | · | 0 | 0 | $0 |
| Guy F. Cipriani | Sr. V.P., Chief Bus. Officer | Feb. 10, 2022 A | 17,901 | 0 | 0 | $0 |
| Richard Tullis | VP, CHIEF SCIENCE OFFICER | June 6, 2014 A | 526,750 | 0 | 0 | $0 |
| Nicolas Gikakis | Director | June 30, 2026 F | 20,663 | 0 | 0 | $0 |
| Chetan Shah | Director | June 30, 2026 F | 20,840 | 0 | 0 | $0 |
| Edward G Broenniman | Director | June 30, 2026 F | 22,363 | 0 | 0 | $0 |
| Angela Rossetti | Director | April 17, 2026 A | 26,207 | 0 | 0 | $0 |
| Sabrina Martucci Johnson | Director | March 31, 2022 F | 33,642 | 0 | 0 | $0 |
| Franklyn S Barry JR | Director | Sept. 30, 2016 M | 10,340 | 0 | 0 | $0 |
| Phillip A Ward | · | March 14, 2014 A | · | 0 | 0 | $0 |
| Calvin M Leung | · | Feb. 23, 2005 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
AEMD Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
SELL
Median target
$13.25
+105.4%
0 0.0%
Strong Buy
0 0.0%
Buy
4 57.1%
Hold
1 14.3%
Sell
2 28.6%
Strong Sell
12-Month Price Target
2 analysts · 2026-09-28Mean target $13.25 +105.4%
Now
Current price $6.45
Low$1.50
Mean$13.25
High$25.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| AEMD | $3M | -0.2 | · | · | -134.5% | · |
| SINT | $15M | -0.6 | -64.7% | -1018.1% | -299.7% | 45.3% |
| CTSO | · | -4.9 | 4.1% | · | · | · |
| IRIX | $20M | -4.5 | 8.2% | -8.4% | -80.8% | 36.5% |
| BMRA | · | -1.8 | -16.2% | · | · | · |
| NMTC | · | -9.9 | 163.5% | · | · | · |
| NDRA | $5M | -0.5 | · | · | -376.5% | · |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 13, 2026